270 related articles for article (PubMed ID: 31115563)
1. HOXC10 overexpression promotes cell proliferation and migration in gastric cancer.
Kim J; Bae DH; Kim JH; Song KS; Kim YS; Kim SY
Oncol Rep; 2019 Jul; 42(1):202-212. PubMed ID: 31115563
[TBL] [Abstract][Full Text] [Related]
2. HOXC10 promotes gastric cancer cell invasion and migration via regulation of the NF-κB pathway.
Yao S; He L; Zhang Y; Ye L; Lai Y; Huang L; Wu L; Wu G; Zhu S
Biochem Biophys Res Commun; 2018 Jun; 501(3):628-635. PubMed ID: 29753747
[TBL] [Abstract][Full Text] [Related]
3. HOXC10 promotes cell migration, invasion, and tumor growth in gastric carcinoma cells through upregulating proinflammatory cytokines.
Li J; Tong G; Huang C; Luo Y; Wang S; Zhang Y; Cheng B; Zhang Z; Wu X; Liu Q; Li M; Li L; Ni B
J Cell Physiol; 2020 Apr; 235(4):3579-3591. PubMed ID: 31552684
[TBL] [Abstract][Full Text] [Related]
4. Homeobox C10 Influences on the Malignant Phenotype of Gastric Cancer Cell Lines and its Elevated Expression Positively Correlates with Recurrence and Poor Survival.
Miwa T; Kanda M; Umeda S; Tanaka H; Tanaka C; Kobayashi D; Suenaga M; Hayashi M; Yamada S; Nakayama G; Koike M; Kodera Y
Ann Surg Oncol; 2019 May; 26(5):1535-1543. PubMed ID: 30673899
[TBL] [Abstract][Full Text] [Related]
5. MiR-136 inhibits gastric cancer-specific peritoneal metastasis by targeting HOXC10.
Zheng J; Ge P; Liu X; Wei J; Wu G; Li X
Tumour Biol; 2017 Jun; 39(6):1010428317706207. PubMed ID: 28656883
[TBL] [Abstract][Full Text] [Related]
6. HOXC10 up-regulation contributes to human thyroid cancer and indicates poor survival outcome.
Feng X; Li T; Liu Z; Shi Y; Peng Y
Mol Biosyst; 2015 Nov; 11(11):2946-54. PubMed ID: 26279264
[TBL] [Abstract][Full Text] [Related]
7. BARX2 expression is downregulated by CpG island hypermethylation and is associated with suppressed cell proliferation and invasion of gastric cancer cells.
Ma J; Xia LL; Yao XQ; Zheng SM; Li S; Xu LS; Sha WH; Li ZS
Oncol Rep; 2020 Jun; 43(6):1805-1818. PubMed ID: 32236603
[TBL] [Abstract][Full Text] [Related]
8. HOXC10 indicates poor survival outcome in gastric cancer and promotes G1/S cell cycle transition through transcriptional repression of p21.
Lin ZH; He JM; Lai SC; Ding N; Jiang Y; He XK; Liu XS; Huang ZH
Neoplasma; 2022 Dec; 69(6):1303-1313. PubMed ID: 36264773
[TBL] [Abstract][Full Text] [Related]
9. HOXC10 promotes proliferation and invasion and induces immunosuppressive gene expression in glioma.
Li S; Zhang W; Wu C; Gao H; Yu J; Wang X; Li B; Jun Z; Zhang W; Zhou P; Shi J; Wang L; Gao Y; Li S; Tao B
FEBS J; 2018 Jun; 285(12):2278-2291. PubMed ID: 29676849
[TBL] [Abstract][Full Text] [Related]
10. Homeodomain-containing gene 10 inhibits cell apoptosis and promotes cell invasion and migration in osteosarcoma cell lines.
Xiong W; Zhou Q; Liu G; Liu XS; Li XY
Tumour Biol; 2017 May; 39(5):1010428317697566. PubMed ID: 28474998
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of the cysteine protease inhibitor, cystatin SN, contributes to cell proliferation and cathepsin inhibition in gastric cancer.
Choi EH; Kim JT; Kim JH; Kim SY; Song EY; Kim JW; Kim SY; Yeom YI; Kim IH; Lee HG
Clin Chim Acta; 2009 Aug; 406(1-2):45-51. PubMed ID: 19463800
[TBL] [Abstract][Full Text] [Related]
12. Methylation of the HOXA10 Promoter Directs miR-196b-5p-Dependent Cell Proliferation and Invasion of Gastric Cancer Cells.
Shao L; Chen Z; Peng D; Soutto M; Zhu S; Bates A; Zhang S; El-Rifai W
Mol Cancer Res; 2018 Apr; 16(4):696-706. PubMed ID: 29453320
[TBL] [Abstract][Full Text] [Related]
13. DNA hypomethylation promotes invasion and metastasis of gastric cancer cells by regulating the binding of SP1 to the CDCA3 promoter.
Yu J; Hua R; Zhang Y; Tao R; Wang Q; Ni Q
J Cell Biochem; 2020 Jan; 121(1):142-151. PubMed ID: 31211445
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor HOXC10 activates the expression of MTFR2 to regulate the proliferation, invasion and migration of colorectal cancer cells.
Xie Y; Chen R; Yan L; Jia Z; Liang G; Wang Q
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34523692
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic reprogramming of HOXC10 in endocrine-resistant breast cancer.
Pathiraja TN; Nayak SR; Xi Y; Jiang S; Garee JP; Edwards DP; Lee AV; Chen J; Shea MJ; Santen RJ; Gannon F; Kangaspeska S; Jelinek J; Issa JP; Richer JK; Elias A; McIlroy M; Young LS; Davidson NE; Schiff R; Li W; Oesterreich S
Sci Transl Med; 2014 Mar; 6(229):229ra41. PubMed ID: 24670685
[TBL] [Abstract][Full Text] [Related]
16. ONECUT2 upregulation is associated with CpG hypomethylation at promoter-proximal DNA in gastric cancer and triggers ACSL5.
Seo EH; Kim HJ; Kim JH; Lim B; Park JL; Kim SY; Lee SI; Jeong HY; Song KS; Kim YS
Int J Cancer; 2020 Jun; 146(12):3354-3368. PubMed ID: 32129880
[TBL] [Abstract][Full Text] [Related]
17. Homeodomain-containing gene 10 contributed to breast cancer malignant behaviors by activating Interleukin-6/Janus kinase 2/Signal transducer and activator of transcription 3 pathway.
Shen J; Wang M; Li F; Yan H; Zhou J
Bioengineered; 2022 Jan; 13(1):1335-1345. PubMed ID: 34983296
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of IFITM1 has clinicopathologic effects on gastric cancer and is regulated by an epigenetic mechanism.
Lee J; Goh SH; Song N; Hwang JA; Nam S; Choi IJ; Shin A; Kim IH; Ju MH; Jeong JS; Lee YS
Am J Pathol; 2012 Jul; 181(1):43-52. PubMed ID: 22609115
[TBL] [Abstract][Full Text] [Related]
19. Potential utility of HOP homeobox gene promoter methylation as a marker of tumor aggressiveness in gastric cancer.
Ooki A; Yamashita K; Kikuchi S; Sakuramoto S; Katada N; Kokubo K; Kobayashi H; Kim MS; Sidransky D; Watanabe M
Oncogene; 2010 Jun; 29(22):3263-75. PubMed ID: 20228841
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic changes and functional study of HOXA11 in human gastric cancer.
Cui Y; Gao D; Linghu E; Zhan Q; Chen R; Brock MV; Herman JG; Guo M
Epigenomics; 2015; 7(2):201-13. PubMed ID: 25590359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
